Breast cancer, as a heterogeneous disease, has five well-established subtypes, including LumA, LumB, Her2 + , Basal-like, and Normal-like, that show distinct molecular profiles and different underlying mechanisms. Here, ERBB2 is linked to breast carcinoma.